Persister studies in leprosy patients after multi-drug treatment

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 73, Issue 2, 2005, Pages 100-104

  Gupta, U D ^a   Katoch, Kiran ^a   Singh, Hari Bhan ^a   Natrajan, Mohan ^a   Katoch, Vishwa Mohan ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; LEPROSTATIC AGENT; MINOCYCLINE; OFLOXACIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COUNT; BORDERLINE LEPROSY; DRUG ADMINISTRATION; DRUG COMBINATION; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; LEPROMATOUS LEPROSY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM LEPRAE; SKIN; TREATMENT FAILURE;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; MIDDLE AGED; MINOCYCLINE; MYCOBACTERIUM LEPRAE; OFLOXACIN; SKIN; TREATMENT FAILURE;

EID: 33745952662     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. CELLONA, R. V., BALEGON, M. V. F., DELA CRUZ, E. C., BURGOS, J. A., ABALOS, R. M., WALSH, G. P., TOPOUKI, R., GELBER, R. H., and WALSH, D. S. Long term efficacy of 2 year W.H.O. multi-drug therapy (M.D.T.) in multibacillary (MB) leprosy patients. Int. J. Lepr. Other Mycobact. Dis. 71 (2003) 308-319.
2. D'ARCY HART, P., and REES, R. J. W. Effect of macrocylon in acute and chronic pulmonary tuberculosis infection in mice a shown by viable and total bacterial count. J. Exp. Pathol. 41 (1960) 414-420.
3. DESIKAN, K. V., and VENKATARAMANAIAH, H. N. A modified method of harvesting M. leprae from foot pads of mice. Lepr. India 48 (1976) 157-162.
4. GIRDHAR, B. K., GIRDHAR, A., and KUMAR, A. Relapses in multi bacillary leprosy patients: effect of length of therapy. Lepr. Rev. 71 (2000) 144-153.
5. GUPTA, U. D., KATOCH, K., NATRAJAN, M., SHARMA, V. D., SHARMA, R. K., SHIVANNAVAR, C. T., and KATOCH, V. M. Viability determination of M. leprae: comparison of normal mouse footpad and bacillary ATP bioluminescence assay. Acta. Leprol. 10 (1997) 209-212.
6. GUPTA, U. D., KATOCH, K., SINGH, H. B., NATRAJAN, M., SHARMA, V. D., and KATOCH, V. M. Detection of viable organisms in leprosy patients treated with multi-drug therapy. Acta. Leprol. 11 (1999) 89-92.
7. KATOCH, K., KATOCH, V. M., NATRAJAN, M., SHARMA,V. D., SINGH, H. B., and GUPTA, U. D. Chemotherapy trials in MB leprosy using conventional and newer drugs ofloxacin and minocycline. Indian J. Dermatol. Venerol. Leprol. 66 (2000) 15-25.
8. KATOCH, K., NATRAJAN, M., BAGGA, A., and KATOCH, V. M. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of M.D.T. Int. J. Lepr. Other Mycobact. Dis. 59 (1991) 248-254.
9. KATOCH, K., RAMU, G., RAMANATHAN, U., SENGUPTA, U., SREEVATSA, SHARMA,V. D., SHIVANNAVAR, C. T., and KATOCH, V. M. Results of a modified W.H.O. regimen in highly bacillated BLLL patients. Int. J. Lepr. Other Mycobact. Dis. 57 (1989) 451-457.
10. KATOCH, K., SREEVATSA, RAMANATHAN, U., and RAMU, G. Pyrazinamide as a part of combination therapy for BL and LL patients - a prelimnary report. Int. J. Lepr. Other Mycobact. Dis. 56 (1988) 1-9.
11. KATOCH, V. M., KATOCH, K., SHIVANNAVAR, C. T., SHARMA,V. D., PATIL, M. A., and BHARADWAJ, V. P. Effect of chemotherapy on viability of M. leprae as determined by ATP content , morphological index and FDA-EB fluorescent staining. Int. J. Lepr. Other Mycobact. Dis. 57 (1989) 615-621.
12. MARCHOUX CHEMOTHERAPY STUDY GROUP. Relapses after long term follow up of multibacillary patients treated by W.H.O.-M.D.T. regimens. Int. J. Lepr. Other Mycobact. Dis. 63 (1995) 195-201.
13. PATTYN, S. R., DOCKX, P., ROLLIER, R., and SAEREDS, I. L. M. leprae persisters after treatment with Dapsone and Rifampicin. Int. J. Lepr. Other Mycobact. Dis. 44 (1976) 154-161.
14. RAMU, G., and DESIKAN, K. V. A study of scrotal biopsy in subsided cases of lepromatous leprosy. Lepr. India 51 (1979) 341-347.
15. RIDLEY, D. S. Bacterial indices. In: Leprosy in Theory and Practice. Bristol: John Wright and Sons, Ltd.,1964. pp. 620-622.
16. SHETTY, V. P., SUCHITRA, K., UPLEKAR, M. W., and ANTIA, N. H. Higher incidence of viable Mycobacxterium leprae within nerve as compared to skin among multibacillary patients released from multi-drug therapy. Lepr. Rev. 68 (1997) 131-138.
17. SHETTY,V. P., SUCHITRA, K., UPLEKAR, M. W., and ANTIA, N. H. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug treated leprosy patients. Lepr. Rev. 63 (1992) 329-336.
18. SHETTY,V. P., WAKADE, A., and ANTIA, N. H. A high incidence of viable Mycobacterium leprae in post-M.D.T. recurrent lesions in tuberculoid leprosy patients. Lepr. Rev. 72 (2001) 337-344.
19. SREEVATSA, GIRDHAR, B. K., and DESIKAN, K. V. Screening of drug resistant strains of M. leprae in lepromatous leprosy patients under multi-drug treatment. Indian J. Med. Res. 87 (1988) 139-143.
20. SUBCOMMITTEE ON CLINICAL TRIALS OF THE CHEMOTHERAPY OF LEPROSY (THELEP) SCIENTIFIC WORKING GROUP OF THE UNDP/WORLD BANK/WHO SPECIAL PROGRAM FOR RESEARCH AND TRAINING IN TROPICAL DISEASE. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Lepr. Rev. 58 (1987) 325-327.
21. WATERS, M. F. R., REES, R. J. W., PEARSON, J. M. H., HELMY, H. S., and LIANG, A. B. G. Ten years of Dapsone in Lepromatous Leprosy: clinical, bacteriological, and histological assessment and the finding of viable leprosy bacilli. Lepr. Rev. 45 (1974) 288-294.
22. WATERS, M. F. R., REES, R. J. W., PEARSON, J. M. H., LIANG, A. B. G., HELMY, H. S., and GELBER, R. H. Rifampicin for lepromatous leprosy: nine years experience. Brit. Med. J. 1 (1978) 133-136.